BN Business News
Add your company to Business Communicator →

Company announcements · 17/11/20261 min read

Akeso Announces NMPA Acceptance of sNDA for Ivonescimab in Combination with Chemotherapy for First-Line Biliary Tract Cancer

EDITORIAL ILLUSTRATIONCACompany announcementsBN
Illustration generated by Business News; it is not a source photograph.

Summary

HONG KONG, Nov. 16, 2026 — Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for ivonescimab in combination with chemotherapy for the...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →